Lbri Pure N Natural Klearaway

Description

No relevant information is available for SPL code 34089-3.

Uses and Indications

This drug is indicated for the treatment of acne. It aids in the clearance of acne pimples and blemishes, facilitating skin healing. Additionally, it helps prevent the formation of new pimples and blemishes.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals are advised to cleanse the skin thoroughly prior to the application of the medication. The product should be dispensed onto a cotton ball, and the soaked pad should be swiped directly onto the blemishes.

Initial treatment should commence with one application at night, or as directed by the prescribing physician. It is imperative to avoid contact with the eyes and mucous membranes during application to prevent irritation or adverse effects.

Contraindications

There are no specific contraindications listed for this product. However, it is advised that if the product is swallowed, the patient should contact a physician or poison control center immediately.

Warnings and Precautions

For external use only. The concurrent use of other topical acne medications may exacerbate skin dryness or irritation. To mitigate the risk of excessive drying, it is recommended to initiate treatment with one application daily, gradually increasing to two or three times daily as necessary or as directed by a healthcare professional. Should bothersome dryness or peeling occur, the frequency of application should be reduced to once per day.

Prolonged use of this product without medical consultation is not advised. In the event of accidental ingestion, immediate contact with a physician or poison control center is essential.

Side Effects

Patients using this product should be aware that it is intended for external use only. The concurrent use of other topical acne medications may lead to increased dryness or irritation of the skin. To mitigate the risk of excessive drying, it is recommended that patients begin with one application daily, gradually increasing to two or three times daily as needed or as directed by a healthcare professional. Should bothersome dryness or peeling occur, patients are advised to reduce the application frequency to once per day.

Additionally, prolonged use of this product without consulting a healthcare provider is not recommended, as it may lead to adverse effects. It is essential for patients to follow these guidelines to minimize the risk of skin irritation and ensure safe usage.

Drug Interactions

Concurrent use of other topical acne medications may lead to increased dryness or irritation of the skin when used simultaneously or immediately following the application of this product. It is advisable to monitor the skin's response closely and consider dosage adjustments or the timing of application to mitigate these effects.

Packaging & NDC

Below are the non-prescription pack sizes of Lbri Pure N Natural Klearaway (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be monitored closely when using this medication. It is essential to keep the product out of reach of children. In the event of accidental ingestion, immediate contact with a physician or poison control center is advised.

To minimize the risk of excessive skin drying, it is recommended to initiate treatment with one application nightly, or as directed by a healthcare professional.

Geriatric Use

There is no specific information regarding the use of LBRI PURE N NATURAL KlearAway (salicylic acid lotion) in geriatric patients. The prescribing information does not provide guidance on dosage adjustments, safety concerns, or special precautions for elderly patients. Therefore, healthcare providers should exercise caution and consider individual patient factors when prescribing this medication to geriatric patients, as the absence of specific data necessitates careful monitoring and assessment of treatment efficacy and safety in this population.

Pregnancy

There is currently no information available regarding the use of LBRI PURE N NATURAL KlearAway (salicylic acid lotion) during pregnancy. The prescribing information does not provide safety concerns, dosage modifications, or special precautions for pregnant patients. Therefore, healthcare professionals should exercise caution when considering the use of this product in pregnant patients, as the potential risks to fetal outcomes are not established. Women of childbearing potential should be advised to consult their healthcare provider before using this product during pregnancy.

Lactation

There are no specific warnings or recommendations regarding the use of L'BRI PURE N NATURAL KlearAway in lactating mothers. Additionally, there are no specific considerations or precautions related to lactation mentioned in the provided text. Therefore, healthcare professionals may consider the use of this product in nursing mothers without specific concerns.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise clinical judgment when considering the use of this medication in patients with liver problems, as the absence of specific guidance necessitates careful evaluation of the patient's overall health status and liver function.

Overdosage

In the event of an overdosage, it is imperative to seek immediate medical attention. If the substance is ingested, the healthcare professional should be contacted without delay, or the individual should reach out to a poison control center for guidance.

Symptoms of overdosage may vary depending on the specific substance involved; however, it is crucial for healthcare providers to be vigilant and assess the patient for any signs of toxicity. Prompt recognition of symptoms can facilitate timely intervention.

Management of overdosage should be tailored to the individual case and may include supportive care and symptomatic treatment as necessary. Healthcare professionals are advised to follow established protocols for the management of overdose situations, ensuring that appropriate measures are taken to mitigate potential harm.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are provided in the insert.

Patient Counseling

Healthcare providers should advise patients to contact a physician or poison control center immediately if the medication is swallowed. It is important for patients to understand the potential risks associated with accidental ingestion and the need for prompt action.

Additionally, healthcare providers should instruct patients on the proper storage of the medication. Patients should be informed to store the medication at room temperature to maintain its efficacy and safety.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature to maintain its integrity and efficacy. No special handling requirements are noted; however, standard precautions should be observed to ensure optimal storage conditions.

Additional Clinical Information

The route of administration for the medication is topical. Clinicians should advise patients that if bothersome dryness or peeling occurs, they should reduce the application frequency to once per day. Additionally, patients should be cautioned to avoid contact with eyes or mucous membranes. No further information is available regarding laboratory tests, abuse potential, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Lbri Pure N Natural Klearaway, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)